PR Newswire
25 May 2023, 06:40 GMT+10
Paradigm Biopharma launches clinical trial website to support development program for knee osteoarthritis therapy.
MELBOURNE, Australia, May 25, 2023 /PRNewswire/ -- With the launch of a new website dedicated to their global clinical trials (https://hope4OA.com), Paradigm Biopharmaceuticals Ltd. (Paradigm Biopharma) aims to provide relief to millions of osteoarthritis (OA) sufferers worldwide by developing a new injectable drug.
Almost one in seven American adults has osteoarthritis
OA is a progressive degenerative disease affecting millions worldwide, with estimates reaching nearly half a billion sufferers. Due to their weight bearing role, 70% of all cases affect the hip or the knee.
Ex-Australian Football League (AFL) player Greg 'Diesel' Williams understands all too well how knee OA can have a devastating impact on your life. Greg explains "If you've got OA people really don't understand what we're going through. It's so painful. It's so sore. It's so, so hard to put up with. And it's about time we did something about it."
Dr Philip Bloom is a specialist sports physician with over 20 years' experience and specialist training in treating and managing musculoskeletal injuries and diseases to maximise function. Dr Bloom explains "We see many ex-athletes who have developed osteoarthritis of the knee. They've gone from being super performers to barely being able to go for a decent walk with their family, and it has quite a disabling effect on their whole life."
Paradigm shift for OA treatments
People with OA need alternative therapeutic solutions, as current therapies often don't provide sufficient relief, leaving people in pain and reducing their quality of life.
Dr Philip Bloom comments "Osteoarthritis of the knee is not just an isolated pain in the knee. It has a trickle-down effect on the rest of your life, particularly in regards to losing the ability to be active, which causes obesity, more aches and pains in other joints, and also psychological problems such as depression and anxiety."
Despite the huge need for effective treatments, there are still no registered treatments that can successfully stop or even slow the disease.
Paradigm Biopharma aims to provide hope to OA sufferers by developing a drug to help relieve pain and improve symptoms in people with knee OA.
This drug has been used to treat joint issues in the veterinary space for over 80 years and is registered for use by veterinarians in over 20 countries to treat arthritis in cats, dogs, horses, and even racing camels.
To facilitate current and potential trial participants, Paradigm has launched a new trial website called Hope4OA.com.
Here everyone can discover trial details and find answers to commonly asked questions. If interested, they are invited to complete an online questionnaire to determine their eligibility as a potential trial participant.
The new site hosts helpful explanations and instructional videos on clinical trials as well as providing links to patient support and further information.
To find out more, go to www.hope4oa.com
About Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) is a late-stage drug development company driven by a purpose to improve patients' health and quality of life by discovering, developing, and delivering pharmaceutical therapies. Paradigm's current focus is developing injectable (subcutaneous) pentosan polysulfate sodium (iPPS) for the treatment of diseases where inflammation plays a major pathogenic role, indicating a need for the anti-inflammatory and tissue regenerative properties of PPS, such as in osteoarthritis (phase 3) and mucopolysaccharidosis (phase 2).
Get a daily dose of Singapore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Singapore Star.
More InformationNEW YORK, New York - The head of the International Atomic Energy Agency (IAEA) says it is deeply concerning that Israel is carrying...
TEL AVIV, Israel - Israel has suffered casualties as Iran fights back from the Jewish state's unprecedented unilateral attacks which...
WEST JERUSALEM, Israel - The Israel Air Force has launched a pre-emptive Pearl Harbour style air raid over Iran, dropping bombs over...
NEW DELHI, India - The world is in shock following Thursday's devastating plane crash in India which has killed at least 290 people,...
WASHINGTON, D.C.: The United States has placed sanctions on two sons of jailed Mexican drug lord Joaquin El Chapo Guzman. These two...
LONDON, UK: Frederick Forsyth, the renowned British author behind The Day of the Jackal and numerous other bestselling thrillers, has...
TOKYO, Japan: Japan has a new top sumo wrestler — and he's Japanese. Onosato, who weighs 191 kilograms (421 pounds), has become a yokozuna,...
LAS VEGAS, Nevada: Khaby Lame, the most followed person on TikTok with millions of fans, has left the United States after being held...
NEW YORK, New York - U.S. stocks tumbled Friday as the world was thrown into turmoil by unprecedented attacks by Israel on Iran. ...
NEW YORK CITY, New York: Paramount Global is cutting 3.5 percent of its U.S. staff as part of another round of layoffs. The company...
SAN FRANCISCO, California: In a move that highlights how the demand for compute power is reshaping the AI industry, OpenAI has signed...
BEIJING/SHANGHAI, China: What started as a surprise toy from a blind box has now entered the elite world of high-value collectibles....